Patents Assigned to C4X Discovery Limited
  • Therapeutic compounds
    Patent number: 11753398
    Abstract: The present invention relates to compounds that are antagonists of the orexin-1 receptor. The compounds have the structural formula (I) defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: September 12, 2023
    Assignee: C4X Discovery Limited
    Inventor: Barrie P. Martin
  • Therapeutic compounds
    Patent number: 11130746
    Abstract: The present invention relates to compounds that are antagonists of the orexin-1 receptor. The compounds have the structural formula (I) defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
    Type: Grant
    Filed: April 28, 2020
    Date of Patent: September 28, 2021
    Assignee: C4X Discovery Limited
    Inventor: Barrie P. Martin
  • Therapeutic compounds
    Patent number: 10696654
    Abstract: The present invention relates to compounds that are antagonists of the orexin-1 receptor. The compounds have the structural formula (I) defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: June 30, 2020
    Assignee: C4X Discovery Limited
    Inventor: Barrie Martin
  • Therapeutic compounds as inhibitors of the orexin-1 receptor
    Patent number: 10611760
    Abstract: The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: April 7, 2020
    Assignee: C4X Discovery Limited
    Inventors: Emma Louise Blaney, Barrie Phillip Martin, Thorsten Nowak, Martin John Watson